G-CSF promotes the development of hepatocellular carcinoma by activating the PI3K/AKT/mTOR pathway in TAM
Aging · 2024
DOI: 10.18632/aging.205922 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging, 2024. Verfasst von Heng Cao und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050011, P.R. China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, TOR Serine-Threonine Kinases, Proto-Oncogene Proteins c-akt. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepatobiliary Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050011, P.R. China.
Zitieren
APA
Cao, H., & Wang, S. (2024). G-CSF promotes the development of hepatocellular carcinoma by activating the PI3K/AKT/mTOR pathway in TAM. Aging. https://doi.org/10.18632/aging.205922
Vancouver
Cao H, Wang S. G-CSF promotes the development of hepatocellular carcinoma by activating the PI3K/AKT/mTOR pathway in TAM. Aging. 2024. doi:10.18632/aging.205922
BibTeX
@article{Cao2024,
author = {Cao, Heng and Wang, Shunxiang},
title = {G-CSF promotes the development of hepatocellular carcinoma by activating the PI3K/AKT/mTOR pathway in TAM},
journal = {Aging},
year = {2024},
doi = {10.18632/aging.205922}
}
EUVIMED